Peg-INF – Ferozsons Laboratories Limited
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C - ScienceDirect
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
ASPIRE Study: SMV + PEG-IFN + RBV for genotype 1 experienced patients - ppt download
Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C | Nature Reviews Gastroenterology & Hepatology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Peginterferon alpha-2a/Peginterferon alpha-2b Pathway (Hepatocyte), Pharmacodynamics
Add-on, switch-to PEG-IFN therapy strategies improve serological response in CHB patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Peg-Interferon lambda + Ribavirin 4 Weeks
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
A BRANCHED METHOXY 40 KDA POLYETHYLENE GLYCOL (PEG) MOIETY OPTIMIZES THE PHARMACOKINETICS (PK) OF PEGINTERFERON a-2A (PEG-IFN) AND MAY EXPLAIN ITS ENHANCED EFFICACY IN CHRONIC HEPATITIS C (CHC)
Frontiers | Interferon and Hepatitis B: Current and Future Perspectives
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study - ScienceDirect
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis | Digestive Diseases and Sciences
PEG-IFN mechanism in HCV infection (Wong and Chen, 2016). | Download Scientific Diagram
Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection | Virology Journal | Full Text
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155 - ScienceDirect
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
Chronic treatment with peg-IFN-α reduces peripheral disease parameters... | Download Scientific Diagram
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
PEG-IFN-ALPHA - Pegylated Interferon-alpha
:max_bytes(150000):strip_icc()/pegasys-568530305f9b586a9e15ec79.jpg "Pegylated Interferon: Definition, Types, Uses")
Pegylated Interferon: Definition, Types, Uses
